Indeed, polymorphisms in the IL18RI-IL18RAP locus are associated with adult and early-onset IBD (54–56), underlining the relevance of the IL-18RI for human disease activity to target both proinflammatory IL-18 and anti-inflammatory IL-37 immune pathways. The gene discussed is IL18; the disease is inflammatory bowel disease.